Wirkstoff

EU-Zulassung für Semaglutid-Tablette: 17% Gewichtsverlust, aber strikte Einnahme

by

The European Medicines Agency (EMA) and regulatory bodies worldwide are closely monitoring the clinical development of oral semaglutide for weight management, a treatment that has demonstrated significant potential in clinical trials such as the OASIS program. While the injectable version of the GLP-1 receptor agonist is already established, the oral formulation requires strict adherence to … Read more

Planetary Health Diet Reduces Mortality by 17%: New Study and Finerenon Insights

by

Adopting a plant-focused nutritional strategy, often referred to as the Planetary Health Diet, is associated with a significant reduction in overall mortality, according to recent clinical findings. This dietary approach, designed to balance human health requirements with environmental sustainability, has been linked to a 17 percent decrease in all-cause mortality in large-scale observational studies. As … Read more